APRIL (protein)

In the cluster of differentiation terminology, APRIL is designated CD256.

The protein encoded by this gene is a member of the tumor necrosis factor ligand (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vivo experiments suggest an important role for APRIL in the long-term survival of plasma cells in the bone marrow. Mice deficient in APRIL have normal immune system development.^[7] However, APRIL-deficient mice have also been reported to possess a reduced ability to support plasma cell survival.^[8] In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM.^[9] Three alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

TNFSF13 has been shown to interact with TNFRSF13B^[10] and B-cell activating factor.^[11]

APRIL is being explored as a target for autoimmune diseases and B cell malignancies.^[12] At least one anti-APRIL monoclonal antibody has been announced to enter phase I clinical trials for multiple myeloma.^[13]

• TNFSF13+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
• Human TNFSF13 genome location and TNFSF13 gene details page in the UCSC Genome Browser.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.